Erythrocytes (E) lacking high incidence blood group antigens were screened by an antiglobulin test with a monoclonal antibody to human complement receptor type 1 (CR1 ; C3b/C4b receptor; CD35) . Some examples of E lacking Knops, McCoy, Swain-Langley, and York antigens, a serologically related group, were not agglutinated . Moreover, E of the null phenotype for these same antigens were nonreactive. To further explore this relationship, E expressing these antigens were surface labeled, solubilized, and incubated with the corresponding blood group-specific antisera. CR1 was immunoprecipitated, indicating that the epitopes recognized by each of these antisera are expressed on CR1 .
Complementreceptortype 1 (CR1 ; C3b/C4b receptor; CD35) is expressed on human erythrocytes (E)t and leukocytes (1, 2). Immune adherence, the attachment of C3b/C4b-bearing immune complexes to primate E or nonprimate platelets, is mediated by this receptor as part of its role in the metabolism of immune complexes (3) . In 1980, Fearon (4) purified CR1, and subsequent studies by Wong et al . (5) and Dykman et al . (6) (7) (8) led to the discovery of an unusual size polymorphism of this receptor. Four codominantly inherited allelic size variants with M, of 190,000, 220,000, 250,000 and 280,000 were identified (9) . Subsequent biochemical and molecular characterization of the variants suggested that a highly homologous repeating unit was duplicated or deleted (reviewed in references 1 and 2) . Further, these investigations pointed out that the structural gene for CRI was not linked to HLA (10) , as had been initially proposed (11, 12) , and also led to the discovery of a new linkage group at 1g32 of complement regulatory and receptor proteins (13, 14) .
In 1975, Rothman et al . (3) analyzed E of individuals lacking common blood group antigens by immune adherence . One individual was immune adherence negative and had a rare blood group phenotype, Rh null; however, other individuals of this phenotype were immune adherence positive. In the early 1980s, two of us (J . P Atkinson, J. J . Moulds) unsuccessfully attempted to find a blood group system with allelic frequencies that paralleled those of the CRI polymorphic size variants. In the present studies, screening of E negative for high frequency blood group antigens with a mAb to CR1 led to the identification of CR1 as a blood group antigen and multiple new alleles that encode protein polymorphisms of CR1 .
Materials and Methods
Antisera. The following antibodies to CRI were used: a rabbit polyclonal antiserum, provided by E. Medof (Case Western Reserve University, Cleveland, OH), and mouse mAbs Ell, provided by N . Hogg (ICRF Laboratories, London, England), and 3139, provided by E. Brown (Washington University School of Medicine, St . Louis, MO) . Blood group antisera, stimulated by transfusion or pregnancy, were obtained from patient samples referred to the consultation laboratory of Gamma Biologicals Inc ., Houston, TX . The antisera designated "Kn/McC" belong to a heterogeneous group related to Knops and McCoy due to their lack of reactivity with the null phenotype MH.
Serological Testing. The anti-CRI mAbs were tested against E lacking multiple antigens in a known blood group system or those that lacked a single antigen of high frequency. Rare E phenotypes obtained through the "Serum, Cells, and Rare Fluid (SCARF) Exchange" were stored in liquid nitrogen until tested . The mAbs were diluted 1 :500 in PBS containing 8% BSA for use in a mouse antiglobulin technique (15) .
Fresh or frozen E from selected individuals were serologically phenotyped for the "Knops-McCoy" ("Kn/McC"), Knops (Kn), McCoy (McC), Swain-Langley (SI), York (Yk), and Cost (Cs) antigens. Saline-suspended E were incubated with the appropriate antisera for 1 h at 37°C followed by a standard antiglobulin procedure (15) .
Immunoprecipitation and Affinity Chromatography. Immunoprecipitation, affinity chromatography, and SDS-PAGE followed by autoradiography were performed as described (6) . E were surface labeled with 1N by a modified lactoperoxidase-glucose oxidase method (6) .
ELISA. mAbs were purified by ammonium sulfate precipitation. Microtiter wells (MaxiSorp ; Nunc, Roskilde, Denmark) were coated with 2.51~g/ml of3D9, the capture mAb. Horseradish peroxidase (Boehringer Mannheim Biochemicals, Indianapolis, IN)-conjugated Ell, the detection mAb, was prepared by a modification of the procedure of Nakane and Kawaoi (16) . After a 2-h incubation at 37°C with the conjugated Ell (10 ng/ml), color was developed with o-phenylenediamine and the absorbance was read at 490 nm in a microplate reader (Dynatech, Chantilly, VA). Samples were referenced relative to a standardized preparation of E ghosts of known CRI number (9) and to purified CRI (17) .
Results
Identification by Hemagglutination of Blood Group Antigens Related to CR1. E negative for high frequency blood group antigens were tested by agglutination with a mAb to CRl (Table 1) . Initially, one example each of Rh null, Jk-3, i adult, Lan-, "Kn/Mc"-, Sla-, Yk'-, and Yk'-/Cs'-was nonreactive . A second example of Rh null, Jk-3, i adult, and Lan-was reactive. These blood groups were not investigated further since they had no apparent relationship to one another and because biochemical data indicate that they could not be CRI (18) . However, additional examples of E negative for the related antigens "Kn/McC"; Sl', and Yk°gave variable reactions, including negative ones. Moreover, E from MH, the null phenotype for "Kn/McC", Kn°, McC', and S11, were not agglutinated . Because of these results and the known serologic relationship between Kn', McC', and Yk, (19) , E expressing these antigens were investigated further by immunoprecipitation.
Knops, McCoy, Swain-Langley, and York Blood Group-specific Antisera Immunoprecipitate CRI . Antisera that reacted with the "Kn/McC", Kn-, McC', Sla, or Yk' blood group antigens were incubated with 125 I-surface-labeled, solubilized E. Multiple examples of each of these antisera precipitated a 220-kD protein that aligned with the common polymorphic size variant of CRl (Fig. 1 A) . In most experiments CRI was the only labeled band identified and, in those cases where another band was noted, it was also present in control (normal serum) lanes.
Further evidence that these blood group antigens are present on CR1 included the following : (a) the protein precipitated by these antisera had an Mr of 190,000 under nonreducing 2-7) . E of a heterozygous donor expressing the two most common polymorphic size variants of CRI (lanes 8-I1) were similarly analyzed. For immunoprecipitation, a mAb to CR1, 3D9 (lane 2) or Ell (lane 9), and the blood group-specific antisera (lanes 4-7 and 9-11) were used. A normal human serum was used as a control (lane 3) . The relatively weak reaction with the anti-Kn' antisera (lane 4) is likely due to its low titer (1 :2 vs . 1 :64 or greater for the others) . These and subsequent autoradiographs are of 5% gels analyzed by SDS-PAGE (reducing conditions) . (B) Comparison of the immunoprecipitated proteins under reducing and nonreducing conditions . Experimental conditions are as in A . Lanes 1-6 and 7-10 were analyzed on separate gels, conditions (Fig. 1 B) and again aligned with CRl ; (b) the antisera recognized the two common polymorphic size variants of CRI (Fig. 1 A, lanes 9-11) ; (c) a protein corresponding to CR1 was not precipitated by these antisera if solubilized E preparations were absorbed with mAbs to CRl (Fig. 2) ; and (d) sera of normal individuals (Fig . 1 A) and antisera to other blood group antigens (data not shown) did not precipitate CRl .
CRI Is Present on E of Antibody Producers. To assess if the antibody producers represent a null phenotype or expressed an anomalously migrating species of CRl, labeled E of four antibody producers (Kna, McC', "Kn/Mc", and Sla) were analyzed by immunoprecipitation followed by SDS-PAGE and autoradiography. In each case, their CRl had an identical Mr to the common polymorphic size variant (data not shown) . Figure 2 . mAbs to CR1 absorb the antigen recognized by the blood group-specific antisera . CR1 was immunoprecipitated from an E preparation by a mixture of mAbs (E11 and 3D9) to CR1 (lane 1) . This E preparation was then incubated with the blood group-specific antisera (lanes 2-4) . A threefold longer exposure of this gel (10 d) did not demonstrate CRI in lanes 2-4. The same result was obtained with an antiserum to Kna (data not shown) . These same antisera precipitated CRI in this and other experiments (Fig. 1 ) from E preparations that had not been precleared of CRl.
The Null Phenotypes for the CRl-related Blood Group Antigens Express Low Copy Number. The E of MH are the null phenotype for the blood group antisera recognizing CR1 . A second individual's E, LM, are the Rh null sample that was nonreactive with Ell (Table 1 ) and those previously described as immune adherence negative (11). LM's E typed identically to the rare MH phenotype .
MH's and Ws E were radiolabeled, solubilized, and then incubated with antibodies to CR1. CRI was immunoprecipitated in both cases and aligned with the common polymorphic CR1 size variant . Their CRl also bound iC3 (Fig .  3) . Densitometric analysis of these autoradiographs suggested that E of MH and LM expressed a low number of CRl. An ELISA was used to more quantitatively assess this observation. The range of CRl/E for 25 unrelated healthy donors was 60-483 (mean, 300) while MH expressed 28 and LM 20 CRi/E . These results confirm the presence of CRl on E of MH and LM and provide an explanation, i .e., low copy number, for the discrepancy between the negative results by agglutination (Table 1) but positive results by immunoprecipitation (Fig. 3) .
To determine their correct phenotype, E of MH and LM were typed by immunoprecipitation with the same antisera used in the agglutination assay. CR1 of LM was precipitated by antisera to Kna, McC', Sla, and Yka. CR1 of MH was precipitated by antisera to McC' and Yka, but this analysis was inconclusive using anti-Kna or anti-Sla.
Discussion
The goal of this study was to find a CRI-related blood group system . The availability of mAbs to CRI provided a tool to screen, by an antiglobulin assay, E deficient in blood group antigens . Some examples of E, lacking a related group, "Kn/McC"; Sla and Yka, were not agglutinated by a mAb 1161 Moulds et al . This table is divided into two parts. The "Null Phenotype" section refers to E that are negative for several antigens in a blood group system . For the remainder of the Table, E to CRI. Further, E of the null phenotype (MH) for these antigens were also nonreactive. These serologic results prompted analysis of the alloantisera specific for these blood group antigens . These antisera specifically precipitated CRl ; therefore, these blood group antigens are expressed on CRI .
Antisera to these CR1-related blood group antigens have 
-l+ Yk'-(2) Cs'-(2) Yk'-/Cs'- (3) traditionally been placed in a collection referred to as hightiter, low-avidity (HTLA) antibodies (19) . They are characterized by their weak reactivity and wide variation in strength of their agglutination reactions . The serological data indicate that "Kn/McC", Kn', McC', Sl', and Yka define distinct but related blood group antigens (18, (20) (21) (22) . Thus, the prior serological data and the present investigation have led to the identification of many alleles that encode new protein polymorphisms of CR1.
Individuals lacking all Kn, McC, and Sl antigens by standard agglutination assays are said to express the "Helgeson phenotype". MH was the first such example with this pattern of reactivity (21) . Our results indicate that this lack of reactivity in the agglutination assay for MH and another individual of the same phenotype (LM) is due to a low number of CR1/E (<30) . This explains why such E are nonreactive in antiglobulin assays and their prior designation as a null phenotype.
A characteristic of HTLA antibodies is a wide variation in the strength of their agglutination reactions with E from different individuals. This serologic observation is accounted for by what is known about the expression of CR1 on E. Thus, the number of CR1 molecules/E vary from individual to individual by >10-fold (23) . This variation of E/CR1 is regulated in part in a Mendelian fashion and is associated with a HindIII RFLP (23) . The presence (L or low allele; gene frequency of 0 .24) or absence (H or high allele; gene frequency of 0 .76) of a HindIII site in an intron in the COON-coding half of the gene (24) correlates with CRl/E . This means that -6% of the population are homozygous for expression of a low CR1 copy number/E. The relative low expression of References Figure 3 . E of two individuals (MH and LM) with the putative null phenotype for the Kn, McC, and SI blood group antigens express CRl . CR1 was purified from E preparations of these two individuals by iC3 affinity chromatography (lanes 2 and 7) orimmunoprecipitation (lanes 3-S and [8] [9] [10] . In parallel, CR1 of E preparations of a control individual was purified (lanes 1 and 6) .
CR1/E, as compared with other proteins bearing blood group antigens, as well as the variability in expression between individuals, undoubtedly accounts for the difficulties experienced by serologists using agglutination assays. It also explains the variable reactions we observed in the analysis of E with a mAb to CRl by agglutination (Table 1) . For example, some Sl'-, Yk°-, or Cs'-E samples were reactive and others were nonreactive with a mAb to CR1. When these E were tested with mAbs and the human blood group antisera specific for CR1, a pattern of reactivity was observed that was correlated with the number of CR1/E (our unpublished observations) . Thus, E with <100-150 CRl/E were negative with all antibodies, and those with >300 CR/E were positive with all antisera.
Prior serological studies have indicated a relationship between Yk' and Cs' . However, while subsequent analyses indicated Yk' was a CR1-related blood group antigen, two lines of evidence suggested that this was not the case for Cs'. First, three Cs'-specific antisera did not precipitate CR1 . Second, Cs' was readily detected on E of donors with a low number of CR1/E, including one of the null phenotypes (LM) (our unpublished data) . Consequently, the serologic association of Yk' and Cs' is not accounted for by our data .
While this work was in progress, an abstract by Rao et al . (25) reported an association between CRl and the KnopsMcCoy group. In contrast to their conclusion that E of the null phenotype (Helgeson) expressed no or a highly abnormal form of CR1, we found that this phenotype is characterized by expression of a low number of CRl, which has normal molecular weight and binds iC3 . In addition, our results indicate that Yk' is also expressed on CR1 .
